These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1093389)

  • 1. Immunization of children with attenuated measles-rubella bivalent vaccine.
    Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L
    Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a new measles-mumps-rubella trivalent vaccine.
    Schwarz AJ; Jackson JE; Ehrenkranz NJ; Ventura A; Schiff GM; Walters VW
    Am J Dis Child; 1975 Dec; 129(12):1408-12. PubMed ID: 128287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
    Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunization of healthy children with mumps-rubella bivalent live vaccine and simultaneous vaccination with mumps-rubella and varicella vaccines].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1271-5. PubMed ID: 1791323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM; Arguedas JA; Buynak EB; Weibel RE; Stokes J; Hilleman MR
    J Pediatr; 1971 Oct; 79(4):599-604. PubMed ID: 5094254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of measles and rubella through use of attenuated vaccines.
    Meyer HM; Hopps HE; Parkman PD; Ennis FA
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):128-35. PubMed ID: 685885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.
    Vesikari T; Ala-Laurila EL; Heikkinen A; Terho A; D'Hondt E; André FE
    Am J Dis Child; 1984 Sep; 138(9):843-7. PubMed ID: 6383020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined measles-rubella vaccines. Virus dose and serologic response.
    Landrigan PJ; Murphy KB; Meyer HM; Parkman PD; Eddins DL; Witte JJ
    Am J Dis Child; 1973 Jan; 125(1):65-7. PubMed ID: 4683961
    [No Abstract]   [Full Text] [Related]  

  • 17. Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine.
    Englund JA; Suarez CS; Kelly J; Tate DY; Balfour HH
    J Pediatr; 1989 Jan; 114(1):37-44. PubMed ID: 2535873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with combined live measles and rubella vaccines.
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):110-5. PubMed ID: 4584450
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15-23 months in Burkina Faso.
    Sirima SB; Ouedraogo A; Barry N; Siribie M; Tiono AB; Nébié I; Konaté AT; Berges GD; Diarra A; Ouedraogo M; Soulama I; Hema A; Datta S; Liang Y; Rotrosen ET; Tracy JK; Jamka LP; Neuzil KM; Laurens MB
    Int J Infect Dis; 2021 Jan; 102():517-523. PubMed ID: 33176205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.